作者: Shigeru Murakami , Masataka Yoshimoto , Hideaki Tsukuma , Hideo Inaji , Yoshifumi Komoike
DOI: 10.2325/JBCS.12.104
关键词:
摘要: Background Ipsilateral breast tumor recurrences (IBTR) after breast-conserving treatment include two different entities: true recurrence (TR) thought to occur when residual cancer cells grow gradually detectable size and new primary (NP) be de novo independently arising in the preserved breast. The patients with ipsilateral are potentially at high risk for subsequent distant metastasis, but many studies do not distinguish between these types of recurrence. aim this study is clarify biological difference TR NP, show clinical significance classifying IBTR into